Chronic Heart Failure in Patients with Nonalcoholic Fatty Liver Disease: Prevalence, Clinical Features, and Relevance

Overview

Journal J Int Med Res

Publisher Sage Publications

Specialty General Medicine

Date 2018 Jul 4

PMID 29968484

Citations 14

Authors

Zichuan Zhang

Peize Wang

Fei Guo

Xinmin Liu

Taiyang Luo

Yang Guan

Hui Chen

Zhanhong Wang

L Zhao

Xiaohai Ma

Qiang Lv

Yin Zhang

Junping Kang

Tong Liu

Xiaohui Liu

Jian-Zeng Dong

Rong Bai

Affiliations

Soon will be listed here.

Abstract

Objective This study was performed to assess the prevalence of nonalcoholic fatty liver (NAFL) in patients with symptomatic congestive heart failure (CHF) and compare the clinical features with those of patients without NAFL. Methods In total, 102 patients with CHF were divided into NAFL and non-NAFL groups according to their hepatic ultrasonography findings. All patients underwent transthoracic echocardiography and cardiac magnetic resonance examination. Follow-up was performed for major cardiovascular events (MACE) and readmission due to heart failure at 1, 3, 6, and 12 months after the index hospitalization. Results NAFL was detected in 37 of 102 patients (36.27%). Compared with the non-NAFL group, patients with NAFL were younger, had a higher body mass index and left ventricular (LV) mass index, and had more severe fibrosis. MACE and readmission occurred in 15 patients in the NAFL group and 29 patients in the non-NAFL group, without a significant difference. Linear regression analysis revealed that after adjusting for confounders, NAFL was independently associated with the LV fibrosis size and the ratio of the LV fibrosis size to the LV mass index. Conclusions NAFL is present in more than one-third of patients with CHF and is associated with the severity of LV fibrosis.

Citing Articles

Risk of cardiovascular disease in elderly subjects with obesity and liver fibrosis and the potential benefit of statin treatment.

Theel W, de Jong V, Cabezas M, Grobbee D, Jukema J, Trompet S Eur J Clin Invest. 2024; 55(3):e14368.

PMID: 39636216 PMC: 11810556. DOI: 10.1111/eci.14368.

Additive effect of metabolic dysfunction-associated fatty liver disease on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T cardiac magnetic resonance feature tracking study.

Tang X, Shi R, Jiang L, Yan W, Han P, Qian W Cardiovasc Diabetol. 2024; 23(1):317.

PMID: 39192259 PMC: 11350936. DOI: 10.1186/s12933-024-02410-z.

Decreased liver-to-spleen ratio in low-dose computed tomography as a biomarker of fatty liver disease reflects risk for myocardial ischaemia.

Hokkanen A, Hamalainen H, Laitinen T, Laitinen T Eur Heart J Imaging Methods Pract. 2024; 1(1):qyad016.

PMID: 39044791 PMC: 11240163. DOI: 10.1093/ehjimp/qyad016.

H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure.

Koch D, Rockey D, Litwin S, Tedford R Dig Dis Sci. 2024; 69(8):3061-3068.

PMID: 38782854 PMC: 11341588. DOI: 10.1007/s10620-024-08438-1.

Effect of bariatric surgery on NAFLD/NASH: a single-centre observational prospective cohort study.

Theel W, Boxma-de Klerk B, Dirksmeier-Harinck F, van Rossum E, Kanhai D, Apers J BMJ Open. 2023; 13(7):e070431.

PMID: 37400234 PMC: 10335561. DOI: 10.1136/bmjopen-2022-070431.

References

Camici P, Ferrannini E, Opie L . Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis. 1989; 32(3):217-38. DOI: 10.1016/0033-0620(89)90027-3. View

Fotbolcu H, Yakar T, Duman D, Karaahmet T, Tigen K, Cevik C . Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. Cardiol J. 2010; 17(5):457-63. View

Sirbu O, Floria M, Dascalita P, Sorodoc V, Sorodoc L . Non-alcoholic fatty liver disease-From the cardiologist perspective. Anatol J Cardiol. 2016; 16(7):534-41. PMC: 5331403. DOI: 10.14744/AnatolJCardiol.2016.7049. View

Scheuermann-Freestone M, Madsen P, Manners D, Blamire A, Buckingham R, Styles P . Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation. 2003; 107(24):3040-6. DOI: 10.1161/01.CIR.0000072789.89096.10. View

Zhou Y, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D . Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000; 97(4):1784-9. PMC: 26513. DOI: 10.1073/pnas.97.4.1784. View

VanWagner L, Wilcox J, Colangelo L, Lloyd-Jones D, Carr J, Lima J . Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study. Hepatology. 2015; 62(3):773-83. PMC: 4549239. DOI: 10.1002/hep.27869. View

Baktir A, Sarli B, Altekin R, Karaman A, Arinc H, Saglam H . Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography. Anatol J Cardiol. 2014; 15(2):137-42. PMC: 5336999. DOI: 10.5152/akd.2014.5212. View

Lautamaki R, Borra R, Iozzo P, Komu M, Lehtimaki T, Salmi M . Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab. 2006; 291(2):E282-90. DOI: 10.1152/ajpendo.00604.2005. View

Petta S, Argano C, Colomba D, Camma C, Di Marco V, Cabibi D . Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. J Hepatol. 2014; 62(4):928-33. DOI: 10.1016/j.jhep.2014.11.030. View

10.

Bonapace S, Perseghin G, Molon G, Canali G, Bertolini L, Zoppini G . Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care. 2012; 35(2):389-95. PMC: 3263884. DOI: 10.2337/dc11-1820. View

11.

Graner M, Nyman K, Siren R, Pentikainen M, Lundbom J, Hakkarainen A . Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease. Circ Cardiovasc Imaging. 2015; 8(1). DOI: 10.1161/CIRCIMAGING.114.001979. View

12.

Goland S, Shimoni S, Zornitzki T, Knobler H, Azoulai O, Lutaty G . Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol. 2006; 40(10):949-55. DOI: 10.1097/01.mcg.0000225668.53673.e6. View

13.

Kim N, Park J, Kim S, Kim Y, Kim D, Cho G . Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Heart. 2014; 100(12):938-43. DOI: 10.1136/heartjnl-2013-305099. View

14.

Young M, McNulty P, Taegtmeyer H . Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation. 2002; 105(15):1861-70. DOI: 10.1161/01.cir.0000012467.61045.87. View

15.

Larsen T, Aasum E . Metabolic (in)flexibility of the diabetic heart. Cardiovasc Drugs Ther. 2008; 22(2):91-5. DOI: 10.1007/s10557-008-6083-1. View

16.

Fintini D, Chinali M, Cafiero G, Esposito C, Giordano U, Turchetta A . Early left ventricular abnormality/dysfunction in obese children affected by NAFLD. Nutr Metab Cardiovasc Dis. 2013; 24(1):72-4. DOI: 10.1016/j.numecd.2013.06.005. View

17.

Ozveren O, Dogdu O, Sengul C, Cinar V, Eroglu E, Kucukdurmaz Z . Deterioration of heart rate recovery index in patients with non-alcoholic fatty liver disease (NAFLD). Med Sci Monit. 2014; 20:1539-43. PMC: 4159245. DOI: 10.12659/MSM.890741. View

18.

Abd El-Kader S, El-Den Ashmawy E . Non-alcoholic fatty liver disease: The diagnosis and management. World J Hepatol. 2015; 7(6):846-58. PMC: 4411527. DOI: 10.4254/wjh.v7.i6.846. View

19.

Ouwens D, Boer C, Fodor M, de Galan P, Heine R, Maassen J . Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats. Diabetologia. 2005; 48(6):1229-37. DOI: 10.1007/s00125-005-1755-x. View